Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics

被引:32
|
作者
Haque, Waqar [1 ]
Verma, Vivek [2 ]
Butler, E. Brian [3 ]
Teh, Bin S. [3 ]
机构
[1] CHI St Lukes Hlth, Dept Radiat Oncol, The Woodlands, TX USA
[2] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA
[3] Houston Methodist Hosp, Dept Radiat Oncol, Houston, TX USA
关键词
Bladder cancer; radiation therapy; chemotherapy; chemoradiation; bladder preservation; cystectomy; COMBINED-MODALITY PROGRAM; ORGAN PRESERVATION; II TRIAL; RTOG; CHEMOTHERAPY; RESECTION; SURVIVAL; OUTCOMES; DISPARITIES; CARCINOMA;
D O I
10.21873/anticanres.11994
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The present study sought to compare the differences in practice patterns, as well as clinical outcomes for patients with muscle-invasive bladder cancer undergoing treatment with either radical cystectomy (RC) or concurrent chemoradiaiton (CRT). Patients and Methods: The National Cancer Data Base (NCDB) was queried for patients diagnosed with T2/T3/T4aN0M0 bladder cancer, between 2004-2013, that received definitive treatment with either RC or CRT. Results: 16,960 patients met the inclusion criteria; 1,450 (8.5%) underwent CRT, while 15,510 (91.5%) were treated with RC. Patients undergoing CRT were older, more likely to be female, African American, received treatment at an academic facility, and lived <20 miles of the treatment facility. CRT was associated with worse median OS (32.8 months vs. 36.1 months; p=0.0004). Conclusion: Older patients are more likely to undergo bladder preservation therapy, while those living farther away from treatment facilities are less likely to under CRT.
引用
收藏
页码:5603 / 5608
页数:6
相关论文
共 50 条
  • [21] Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer
    Chedgy, Edmund Charles Paul
    Black, Peter C.
    JAMA ONCOLOGY, 2016, 2 (07) : 855 - 856
  • [22] Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer
    Kotha, Nikhil V.
    Kumar, Abhishek
    Nelson, Tyler J.
    Qiao, Edmund M.
    Qian, Alex S.
    Voora, Rohith S.
    Mckay, Rana R.
    Rose, Brent S.
    Stewart, Tyler F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (06) : 274.e1 - 274.e6
  • [23] Comparison of Radical Cystectomy with Conservative Treatment in Geriatric (≥ 80) Patients with Muscle-Invasive Bladder Cancer
    Martini, Thomas
    Mayr, Roman
    Wehrberger, Clemens
    Dechet, Christopher
    Lodde, Michele
    Palermo, Salvatore
    Trenti, Emanuela
    Comploj, Evi
    Pycha, Armin
    Madersbacher, Stephan
    INTERNATIONAL BRAZ J UROL, 2013, 39 (05): : 622 - 630
  • [24] Oncological Outcome of Primary versus Secondary Muscle-Invasive Bladder Cancer Is Comparable after Radical Cystectomy
    Aziz, A.
    Gierth, M.
    Fritsche, H. M.
    May, M.
    Otto, W.
    Denzinger, S.
    Wieland, W. F.
    Merseburger, A.
    Riedmiller, H.
    Kocot, A.
    Burger, M.
    UROLOGIA INTERNATIONALIS, 2013, 91 (01) : 97 - 102
  • [25] Laparoscopic versus Open Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Single Institute Comparative Analysis
    Aboumarzouk, Omar M.
    Drewa, Tomasz
    Olejniczak, Pawel
    Chlosta, Piotr L.
    UROLOGIA INTERNATIONALIS, 2013, 91 (01) : 109 - 112
  • [26] Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium
    Gopalakrishnan, Dharmesh
    Elsayed, Ahmed S.
    Hussein, Ahmed A.
    Jing, Zhe
    Li, Qiang
    Wagner, Andrew A.
    Aboumohamed, Ahmed
    Roupret, Morgan
    Balbay, Derya
    Wijburg, Carl
    Stockle, Michael
    Dasgupta, Prokar
    Khan, Muhammad Shamim
    Wiklund, Peter
    Hosseini, Abolfazl
    Peabody, James
    Shigemura, Katsumi
    Trump, Donald
    Guru, Khurshid A.
    Chatta, Gurkamal
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (03) : 197 - 205
  • [27] Adjuvant Treatment of Residual Disease Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle Invasive Bladder Cancer
    Krebs, Markus
    Sokolakis, Ioannis
    Seiler, Roland
    Daneshmand, Siamak
    Grivas, Petros
    Gakis, Georgios
    BLADDER CANCER, 2020, 6 (04) : 525 - 535
  • [28] Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer
    Kusaka, Ayumu
    Hatakeyama, Shingo
    Hosogoe, Shogo
    Hamano, Itsuto
    Iwamura, Hiromichi
    Fujita, Naoki
    Fukushi, Ken
    Narita, Takuma
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ito, Hiroyuki
    Yoshikawa, Kazuaki
    Kawaguchi, Toshiaki
    Ohyama, Chikara
    MEDICAL ONCOLOGY, 2017, 34 (05)
  • [29] Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer
    Stevenson, Scott M.
    Danzig, Matthew R.
    Ghandour, Rashed A.
    Deibert, Christopher M.
    Decastro, G. Joel
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1172 - 1177
  • [30] Effects of neoadjuvant chemotherapy on pathological parameters and survival in patients undergoing radical cystectomy for muscle-invasive bladder cancer
    Caglayan, Alper
    Akbulut, Ziya
    Atmaca, Ali Fuat
    Altinova, Serkan
    Kilic, Metin
    Balbay, Mevlana Derya
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 623 - 629